|
⚲
|
| Keyboard |
| Alerce Investment Management LP
✚
|
|
|---|---|
| CRD # | 285746 |
| SEC # | 801-108686 |
| CIK # | 0001844002 |
| AUM | 226.9 M (2026-03-27) |
| Employees | 4 (50% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 312-448-5500 |
| Address | 676 North Michigan Ave Chicago, IL 60611-2895 |
| Source | [IAPD] [EDGAR] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Annexon Inc | 38.0 | ||
| Akebia Therapeutics Inc | 10.9 | ||
| American Well Corp | 3.8 | ||
| Zeta Acquisition Corp II | 0.0 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Alerce Medical Technology Partners LP Class 1A | [2026-03-27] | 195.5 M | 8.3 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Alerce Medical Technology Partners LP Class 2025-2 | [2026-03-27] | 195.5 M | 12.0 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Alerce Medical Technology Partners LP Class 2024-1 | [2025-03-26] | 195.5 M | 36.1 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Alerce Medical Technology Partners LP Class 2024-2 | [2025-03-26] | 195.5 M | 4.9 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Alerce Medical Technology Partners LP Class 2023-1 | [2024-03-26] | 195.5 M | 8.8 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Alerce Medical Technology Partners LP Class 2023-2 | [2024-03-26] | 195.5 M | 36.9 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Alerce Medical Technology Partners LP | [2023-03-31] | 195.5 M | 77.2 M |
| Filed 2025-11-20 (D/A) · Exemption 506(c), 3(c), 3(c)(1) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | SMTP Co-Invest II AWC LP | [2020-03-29] | 0.4 M | |
| Offered $15,000,000 · Filed 2019-12-10 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $15,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | SRX Investment II LP | [2020-03-29] | 1.3 M | |
| Offered $15,000,000 · Filed 2019-09-13 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $15,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | SRX Investment LP | [2019-03-29] | 0.8 M | |
| Offered $10,000,000 · Filed 2018-12-07 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $10,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | SMTP Co-Invest I LP | [2018-03-30] | 0.4 M | |
| Offered $15,000,000 · Filed 2017-10-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $15,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Satter Co-Invest Partners LP | [2017-03-21] | 4.1 M | |
| PE | Satter Medical Technology Partners LP | [2017-03-21] | 26.6 M | |
| Offered $125,000,000 · Filed 2017-01-10 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining $125,000,000 · Duration One year or less · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 12 | 5.5 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 13 | 217.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 3.7 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 26 | 226.9 |
| By Discretionary | ||
| Discretionary | 26 | 226.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 26 | 226.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 226.9 | |
| Total | 26 | 226.9 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Muneer Satter | Executive Officer | 33 | 4 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001844002] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional, Retail |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
Galliott Capital Advisors LLC
✚
|
CA | 249.0 M |
|
City Different Holdings LP
✚
|
NM | 244.4 M |
|
Heights LLC
✚
|
CA | 239.2 M |
|
Ninth Eternity Asset Management LLC
✚
|
MA | 238.6 M |
|
Secfi Advisory Limited
✚
|
NY | 225.9 M |
|
Reicon Wealth Advisors LLC
✚
|
GA | 220.1 M |
|
Refined Wealth Management
✚
|
UT | 210.9 M |
|
Alliance Investment Management LLC
✚
|
MI | 206.8 M |
|
McKinley Alaska Private Investment LLC
✚
|
AK | 206.2 M |
|
LC VERO Manager LLC
✚
|
NY | 205.6 M |